6T3V image
Deposition Date 2019-10-11
Release Date 2020-11-18
Last Version Date 2024-01-24
Entry Detail
PDB ID:
6T3V
Keywords:
Title:
Psychrophilic aromatic amino acids aminotransferase from Psychrobacter sp. B6 cocrystalized with substrate analog - malic acid
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.62 Å
R-Value Free:
0.16
R-Value Work:
0.12
R-Value Observed:
0.12
Space Group:
P 65 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Aminotransferase
Chain IDs:A
Chain Length:398
Number of Molecules:1
Biological Source:Psychrobacter sp. B6
Primary Citation
Structural Evidence of Active Site Adaptability towards Different Sized Substrates of Aromatic Amino Acid Aminotransferase from Psychrobacter Sp. B6.
Materials 14 ? ? (2021)
PMID: 34204354 DOI: 10.3390/ma14123351

Abstact

Aromatic amino acid aminotransferases present a special potential in the production of drugs and synthons, thanks to their ability to accommodate a wider range of substrates in their active site, in contrast to aliphatic amino acid aminotransferases. The mechanism of active site adjustment toward substrates of psychrophilic aromatic amino acid aminotransferase (PsyArAT) from Psychrobacter sp. B6 is discussed based on crystal structures of complexes with four hydroxy-analogs of substrates: phenylalanine, tyrosine, tryptophan and aspartic acid. These competitive inhibitors are bound in the active center of PsyArAT but do not undergo transamination reaction, which makes them an outstanding tool for examination of the enzyme catalytic center. The use of hydroxy-acids enabled insight into substrate binding by native PsyArAT, without mutating the catalytic lysine and modifying cofactor interactions. Thus, the binding mode of substrates and the resulting analysis of the volume of the catalytic site is close to a native condition. Observation of these inhibitors' binding allows for explanation of the enzyme's adaptability to process various sizes of substrates and to gain knowledge about its potential biotechnological application. Depending on the character and size of the used inhibitors, the enzyme crystallized in different space groups and showed conformational changes of the active site upon ligand binding.

Legend

Protein

Chemical

Disease

Primary Citation of related structures